Dacarbazine (Hospira Worldwide, Inc.)
Welcome to the PulseAid listing for the Dacarbazine drug offered from Hospira Worldwide, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira Worldwide, Inc. |
| NON-PROPRIETARY NAME: | DACARBAZINE |
| SUBSTANCE NAME: | DACARBAZINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2003-07-01 |
| END MARKETING DATE: | 0000-00-00 |
Dacarbazine HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dacarbazine from Hospira Worldwide, Inc. |
| LABELER NAME: | Hospira Worldwide, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/mL) |
| START MARKETING DATE: | 2003-07-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61703-327_58c388d8-1938-4fb1-a54b-fda12b9ff160 |
| PRODUCT NDC: | 61703-327 |
| APPLICATION NUMBER: | ANDA075940 |
Other DACARBAZINE Pharmaceutical Manufacturers / Labelers:
